Sean Duffy Sells 12,944 Shares of Omada Health (NASDAQ:OMDA) Stock

Key Points

• CEO Sean Duffy sold 12,944 Omada Health shares at an average price of $20.40, generating $264,057.60; he retained 411,861 shares after the transaction.
• Omada Health shares fell 5.3% to $19.11, while the company reported quarterly revenue of $78.05 million and adjusted its loss to $0.05 per share, beating analyst expectations.
• Analyst sentiment remains broadly positive, with a “Moderate Buy” consensus and a $24.75 average price target; several institutions, including Perceptive Advisors and Millennium Management, recently increased their positions.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 12,944 shares of the company's stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $20.40, for a total value of $264,057.60. Following the completion of the transaction, the chief executive officer owned 411,861 shares of the company's stock, valued at $8,401,964.40. The trade was a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Omada Health Stock Down 5.3%

Shares of NASDAQ OMDA traded down $1.07 during trading hours on Wednesday, reaching $19.11. 2,078,593 shares of the stock traded hands, compared to its average volume of 1,227,378. The company has a market capitalization of $1.14 billion, a P/E ratio of -70.78 and a beta of 1.73. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The company's 50-day simple moving average is $20.15 and its two-hundred day simple moving average is $16.10.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on OMDA shares. BTIG Research initiated coverage on shares of Omada Health in a research note on Friday, July 17th. They set a "buy" rating and a $30.00 target price on the stock. Barclays lifted their price objective on Omada Health from $20.00 to $25.00 and gave the company an "overweight" rating in a research report on Monday. Needham & Company LLC reissued a "buy" rating and issued a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratings lowered Omada Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday, July 13th. Finally, Citizens Jmp increased their price objective on Omada Health from $21.00 to $27.00 and gave the stock a "market outperform" rating in a report on Monday, July 20th. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $24.75.

Institutional Investors Weigh In On Omada Health

Institutional investors have recently made changes to their positions in the company. Perceptive Advisors LLC bought a new stake in shares of Omada Health during the second quarter valued at approximately $44,402,000. Millennium Management LLC boosted its stake in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company's stock valued at $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Omada Health in the 4th quarter worth $16,948,000. SG Americas Securities LLC bought a new stake in shares of Omada Health in the 1st quarter worth $10,401,000. Finally, Madryn Asset Management LP purchased a new position in shares of Omada Health in the fourth quarter worth $9,212,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source